265 ADI-925: an allogeneic off-the-shelf chimeric adapter (CAd) γδ T cell therapy targeting NKG2D ligand-expressing cancers

• Xue Yang,
• Marissa Herrman,
• Jonathan Wong,
• Ramandeep Kaur,
• Taylor Barca,
• Kevin P Nishimoto,
• Maryam Tabrizizad,
• Arun Bhat,
• Blake T Aftab,
• Morgan Smith-Boeck,
• Louise Kiru,
• Kyle McSweeney,
• Amy Doan,
• Kimberly Rodriquez,
• Smitha Rao Yelaguli Gundurao,
• Ngoc T Hoang,
• Hayden Tessman,
• Taylor Wingfield,
• Philip A Storm,
• Christopher J Rold,
• Swapna Panuganti

Affiliations

Xue Yang

Adicet Bio Inc., Redwood City, CA, USA

Marissa Herrman

Adicet Therapeutics, Menlo Park, California, USA

Jonathan Wong

1Department of Renal Medicine, Lister Hospital, Hertfordshire, UK

Ramandeep Kaur

1Primary Care Clinical Sciences, NIHR School for Primary Care Research, University of Birmingham, Edgbaston, Birmingham,  UK

Taylor Barca

Adicet Therapeutics, Menlo Park, California, USA

Kevin P Nishimoto

Adicet Therapeutics, Menlo Park, California, USA

Maryam Tabrizizad

Adicet Therapeutics, Menlo Park, California, USA

Arun Bhat

Adicet Therapeutics, Menlo Park, California, USA

Blake T Aftab

Adicet Therapeutics, Menlo Park, California, USA

Morgan Smith-Boeck

Adicet Bio, Inc., Redwood City, CA, USA

Louise Kiru

Adicet Bio Inc., Redwood City, CA, USA

Kyle McSweeney

Adicet Bio Inc., Redwood City, CA, USA

Amy Doan

Adicet Bio Inc., Redwood City, CA, USA

Kimberly Rodriquez

Adicet Bio Inc., Redwood City, CA, USA

Smitha Rao Yelaguli Gundurao

Adicet Bio Inc., Redwood City, CA, USA

Ngoc T Hoang

Adicet Bio Inc., Redwood City, CA, USA

Hayden Tessman

Adicet Bio Inc., Redwood City, CA, USA

Taylor Wingfield

Adicet Bio Inc., Redwood City, CA, USA

Philip A Storm

Adicet Bio Inc., Redwood City, CA, USA

Christopher J Rold

Adicet Bio Inc., Redwood City, CA, USA

Swapna Panuganti

Adicet Bio Inc., Redwood City, CA, USA